Skip to main content
Quest Diagnostics

Prevalence of Hepatitis D Virus from Remnant Hepatitis B Surface Antigen Positive Specimens in the United States

ASM-CVS 2024

American Society for Microbiology Clinical Viral Symmposium

Long Beach, CA, Oct 7-10, 2024

Poster presentation: Prevalence of Hepatitis D Virus from Remnant Hepatitis B Surface Antigen Positive Specimens in the United States

Authors: Marlowe EM, Swanson BE, Realegeno SE, Kagan RM, Meyer WA III

Specialty: Infectious disease

Related content

Conference Presentation
Seroprevalence of Hepatitis D Virus (HDV) antibodies in patient specimens with detectable HDV RNA
Conference Presentation
Epidemiologic Burden of Hepatitis D Virus in the United States
Conference Presentation
Very low rates of hepatitis delta virus testing among a large national cohort of patients with chronic hepatitis B infection

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.